For research use only. Not for therapeutic Use.
RSU 1131(Cat No.:I035758)is a selective and potent inhibitor of the protein kinase C (PKC) family, specifically targeting PKCα and PKCβ isoforms. PKC is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis, making RSU 1131 an important tool in cancer research. By inhibiting PKC activity, RSU 1131 has been studied for its potential to suppress tumor growth and metastasis in various cancer types, including breast and prostate cancers. Additionally, it is being explored for its possible role in regulating immune responses and inflammatory diseases. Further research is needed to assess its therapeutic potential.
Catalog Number | I035758 |
CAS Number | 88876-89-5 |
Synonyms | RSU 1131; RSU1131; RSU-1131; |
Molecular Formula | C9H14N4O3 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 1-(2-methylaziridin-1-yl)-3-(2-nitroimidazol-1-yl)propan-2-ol |
InChI | InChI=1S/C9H14N4O3/c1-7-4-12(7)6-8(14)5-11-3-2-10-9(11)13(15)16/h2-3,7-8,14H,4-6H2,1H3 |
InChIKey | AFLZZBWHQVDQKY-UHFFFAOYSA-N |
SMILES | CC1CN1CC(CN2C=CN=C2[N+](=O)[O-])O |